Antihypertensive drugs Flashcards
central sympatholytic drugs
that act directly or indirectly stimulate central presynaptic α2 adrenergic receptors , with inhibitory effect on peripheral sympathetic control.
Sympatholytic with central action
Clonidine
1) stimulates central α2 adrenergic receptors from the bulbous and hypothalamic structures, decreasing peripheral sympathetic tone and blood pressure.
2) acts on non - adrenergic receptors, respectively imidazoline receptors (I1 receptors).
3) It reduces blood flow to the cerebral and splanchnic area, but without decreasing renal blood flow and glomerular filtration,
!!! which recommends the use of clonidine in patients that associate hypertension with renal failure
4) It does not decrease peripheral resistance and does not produce orthostatic hypotension.
Adverse reactions of clonidine
it frequently causes :
1) sedation,
2) drowsiness,
3) constipation,
4) dry mouth due to inhibition of salivary secretion by central mechanism.
5) It is contraindicated in patients who associate depressive psychosis (may reactivate psychosis).
Sympatholytic with central action
Methyldopa
1) a is analogous to DOPA.
2) It penetrates the brain and substitutes DOPA in the
metabolic chain, causing the synthesis of alpha-methylnoradrenaline (false neurotransmitter)
that stimulates central α2-adrenergic receptors, with the inhibition of the peripheral sympathetic activity.
3) It is used in hypertensives with renal failure. It may be associated with furosemide and vasodilators.
4) It is also indicated in hypertension in pregnancy.
Adverse reactions of Methylodopa
1) sedation,
2) drowsiness,
3) depression,
4) nightmares,
5) dizziness.
Sympatholytic with central action
Moxonidine and Rilmenidine
1) lower blood pressure, especially as a result of the action of the imidazoline (I1) receptors in the bulb.
2) Associate weaker central agonist α2 effect.
Ganglioplegics (trimetaphan)
- act by :
- blocking nicotine receptors from sympathetic and parasympathetic vegetative ganglia and
- decrease the blood pressure with pronounced
orthostatic character. - Sensitization of the heart to the action of catecholamines occurs, increasing the risk of myocardial ischemia and arrhythmias
- The sudden paralysis of the sympathetic and parasympathetic vegetative ganglia explains the numerous adverse reactions and the limitation of the clinical use of these drugs
Neurosympatholytics
act at :
- the presynaptic component of peripheral sympathetic synapses,
- decrease the availability of catecholamines in the synaptic cleft and the blood pressure.
- Guanethidine enters
> the presynaptic terminations, by the same transport mechanism that ensures the recovery of noradrenaline,
> stabilizes the presynaptic membrane and produces a “presynaptic block”, preventing the release of noradrenaline from sympathetic endings.
Neurosympatholytics
Adverse reactions of Guanethidine
- produces a marked hypotension, with a pronounced orthostatic character.
- It is reserved for cases of severe hypertension or not responding to other treatment.
Neurosympatholytics
Reserpine
- prevents the recovery of noradrenaline in the storage vesicles
- Remained in the cytoplasm of presynaptic termination, noradrenaline is largely metabolized by the MAO, thus decreasing the availability of the neurotransmitter.
- In the central nervous system, synaptic deposits of dopamine and serotonin also decrease, which explains other effects of reserpine
(sedation-depression, extrapyramidal disorders)
** The hypotensive effect is slow
Adverse reactions of Reserpine
1) sedation,
2) depressive states,
3) nasal congestion,
4) pyrosis,
5) diarrhea,
6) xerostomia,
7) taste changes,
8) pain and / or swelling of the salivary glands, rarely bleeding of the buccal mucosa.
Alpha-adrenergic blockers
Adrenergic α-blockers
produce vasodilation by blocking α1 receptors
Alpha-adrenergic blockers
Non-selective α-adrenergic blockers :
phentolamine and phenoxybenzamine,
are used in the treatment of secondary hypertension in pheochromocytoma.
The combination with β-adrenergic blockers is required to counteract the effects of catecholamines on the heart.
In the treatment of essential hypertension, selective α1-blockers, such as _____ are currently used.
prazosin, doxazosin, terazosin,
Prazosine
1) blocks postsynaptic α1 adrenergic receptors in the vascular smooth muscle without affecting presynaptic alpha2 receptors.
- As a result, presynaptic α2 receptors may be triggered
by norepinephrine released into the synaptic cleft.
2) By blocking the α1 receptors it produces
arterial vasodilation (with decreased peripheral resistance) and venodilation (with decreased
venous return), which explains the usefulness of prazosin and in the treatment of heart failure.
3) Renal circulation is unaffected. It is used in the medium and severe forms of hypertension, generally being associated with a diuretic, possibly with other antihypertensives
Prazosin acts as an antagonist also at the level of
α1 receptors located in the prostate capsule,
improving the symptoms secondary to prostate adenoma.
It is advantageous in hypertensive men who associate benign prostatic hyperplasia
Side effects of Prazosine
1) orthostatic hypotension,
2) headache,
3) nausea,
4) xerostomia,
5) polyarthralgia.
Rarely, it may aggravate the clinical status of hypertensives that associate angina pectoris of effort, which is why in such patients the association with a β blocker is indicated.
Doxazosin
1) is an α1 selective blocker,
2) with a prazosin-like effect and
3) longer duration of action.
It is indicated in the treatment of hypertension and symptomatology of prostate adenoma
Β-adrenergic blockers
1) lower blood pressure in particular by inhibiting renin
(β1-adrenergic) secretion.
2) It associates cardiac depression (with decreased heart rate).
They can be given alone or in combination with a diuretic and or vasodilator. In the case of
association with vasodilators, they have the advantage that they prevent reflex tachycardia
indications , usefulness , recommandations of
Β-adrenergic blockers
- indicated in all forms of hypertension
- They are useful in hypertension associated with
ischemic heart disease and / or arrhythmia. - It is also recommended in young people with
hypertension due to adrenergic hyperactivity
Adverse reactions of Β-adrenergic blockers
are due to decreased sympathetic beta-adrenergic control and consist of:
- worsening heart failure
- bradycardia,
and in the case of non-selective beta-blockers :
- bronchoconstriction and
- aggravation of peripheral ischemia are added.
!! Administration of βblockers to diabetics under hypoglycemic medication (insulin preparations or oral
antidiabetics) requires caution, as they may promote hypoglycemic reactions and mask the symptoms of hypoglycemia
Propranolol
1) a non-selective β-blocker,
2) without intrinsic sympathomimetic activity and
3) with quinidine membrane effect,
4) is the oldest drug in the group and has long been used as an antihypertensive agent.
!! Is contraindicated in patients who associate asthma or peripheral vascular-spastic disorders
Atenolol
1) is a β1 blocker.
2) It is excreted renal.
In patients with renal impairment, dose reduction is required.